Dr Benjamin Levy on the Management of Lung Cancer in the COVID-19 Era - a podcast by Research To Practice

Dr Benjamin Levy from Johns Hopkins comments on changes to the surgical and targeted treatment of lung cancer during COVID-19 and challenges in the management of immune-related adverse events with immune checkpoint inhibitors.
RTP Lung Cancer Summit Presentations (https://www.researchtopractice.com/LungCancerSummit20/)Additional Resources
* Banna G et al. How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere. ESMO Open 2020;5(2). Abstract (https://pubmed.ncbi.nlm.nih.gov/32245904/)Kumar S et al. Alternative multidisciplinary management options for locally advanced non-small cell lung cancer during the COVID-19 global pandemic. J Thorac Oncol 2020;[Online ahead of print]. Abstract (https://pubmed.ncbi.nlm.nih.gov/32360578)Thoracic Surgery Outcomes Research Network, Inc. COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network. Ann Thorac Surg 2020;[Online ahead of print]. Abstract (https://pubmed.ncbi.nlm.nih.gov/32278755)

Further episodes of Oncology Today with Dr Neil Love

Further podcasts by Research To Practice

Website of Research To Practice